Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00111215 · ClinicalTrials.gov registry record · NA
Treatment and Management of Women With Bleeding Disorders
A NA study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00111215 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 100 participants.
The verdict
NCT00111215, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether oral contraceptives, desmopressin acetate, and/or tranexamic acid are effective in the treatment of women with menorrhagia who are diagnosed with a bleeding disorder.
Interventions
- DRUG Tranexamic Acid
- DRUG Desmopressin Acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-01 |
| Est. Completion | 2006-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00111215
The ClinicalTrials.gov registry entry for NCT00111215 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tranexamic Acid is the first listed.
NCT00111215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00111215 about?
NCT00111215 is a clinical study titled "Treatment and Management of Women With Bleeding Disorders". The purpose of the study is to determine whether oral contraceptives, desmopressin acetate, and/or tranexamic acid are effective in the treatment of women with menorrhagia who are diagnosed with a bleeding disorder.
What is the current status of trial NCT00111215?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2001-01. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00111215?
The interventions under investigation include: Tranexamic Acid (DRUG), Desmopressin Acetate (DRUG).
Who is sponsoring clinical trial NCT00111215?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.